ارتداد الوريد الصافن الكبير الإضافي العَرَضي عند فشل العلاج المحافظ في السيطرة على الأعراض

For patients with symptomatic accessory GSV reflux, the SCAI guideline panel suggests ablation therapy plus conservative management rather than conservative management alone (conditional recommendation, very low certainty of evidence).

When accessory veins are associated with pathology such as ulcers or other symptoms, patients may reasonably choose ablation therapy.

As with GSV reflux with or without SSV reflux, the data from the included studies indicate that ablation therapy probably reduces median days to ulcer healing (MD, 31.73 fewer days; 95% CI, 45.1-18.3).

Ablation therapy may also reduce the rate of ulcer recurrence at 2 years (RR, 0.39; 95% CI, 0.18-0.81), lead to symptom improvement (VCSS MD, 2.1 lower; 95% CI, 2.99-1.21), and improve QoL (EQ-ED-5L MD, 1.3 higher; 95% CI, 2.1-4.8).